Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · IEX Real-Time Price · USD
8.84
+0.05 (0.57%)
At close: May 3, 2024, 4:00 PM
8.88
+0.04 (0.45%)
After-hours: May 3, 2024, 7:57 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 500 employees on December 31, 2023. The number of employees did not change compared to the previous year.
Employees
500
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$89,150
Profits / Employee
-$656,132
Market Cap
2.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 500 | 0 | - |
Dec 31, 2022 | 500 | 100 | 25.00% |
Dec 31, 2021 | 400 | 184 | 85.19% |
Dec 31, 2020 | 216 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amneal Pharmaceuticals | 7,700 |
Evotec SE | 4,952 |
UFP Technologies | 3,093 |
Galapagos NV | 1,123 |
agilon health | 1,117 |
Agios Pharmaceuticals | 386 |
Rocket Pharmaceuticals | 268 |
Dyne Therapeutics | 123 |
RXRX News
- 2 days ago - Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9 - GlobeNewsWire
- 3 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX - Invezz
- 18 days ago - Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer - GlobeNewsWire
- 5 weeks ago - Recursion Publishes Annual Environmental, Social and Governance Report - GlobeNewsWire
- 7 weeks ago - Not just Soundhound, these AI stocks are also riding Nvidia wave - Invezz
- 7 weeks ago - Recursion Announces Plans to Open New Office in London - GlobeNewsWire
- 2 months ago - Recursion Hosts Second Annual Rare Disease Day Events for Utah's Rare Disease Community - GlobeNewsWire